vs
Side-by-side financial comparison of Acadia Healthcare Company, Inc. (ACHC) and Datadog (DDOG). Click either name above to swap in a different company.
Datadog is the larger business by last-quarter revenue ($953.2M vs $829.0M, roughly 1.1× Acadia Healthcare Company, Inc.). Datadog runs the higher net margin — 4.9% vs 0.5%, a 4.3% gap on every dollar of revenue. On growth, Datadog posted the faster year-over-year revenue change (29.2% vs 7.5%). Over the past eight quarters, Datadog's revenue compounded faster (24.9% CAGR vs 2.0%).
Acadia Healthcare Company, Inc. is an American provider of for-profit behavioral healthcare services. It operates a network of over 225 facilities across the United States and Puerto Rico.
Datadog, Inc. is an American company that provides an observability service for cloud-scale applications, providing monitoring of servers, databases, tools, and services, through a SaaS-based data analytics platform. Founded and headquartered in New York City, the company is a publicly traded entity on the Nasdaq stock exchange.
ACHC vs DDOG — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $829.0M | $953.2M |
| Net Profit | $4.5M | $46.6M |
| Gross Margin | — | 80.4% |
| Operating Margin | — | 1.0% |
| Net Margin | 0.5% | 4.9% |
| Revenue YoY | 7.5% | 29.2% |
| Net Profit YoY | -50.8% | 2.1% |
| EPS (diluted) | $0.05 | $0.13 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $829.0M | — | ||
| Q4 25 | $821.5M | $953.2M | ||
| Q3 25 | $851.6M | $885.7M | ||
| Q2 25 | $869.2M | $826.8M | ||
| Q1 25 | $770.5M | $761.6M | ||
| Q4 24 | $774.2M | $737.7M | ||
| Q3 24 | $815.6M | $690.0M | ||
| Q2 24 | $796.0M | $645.3M |
| Q1 26 | $4.5M | — | ||
| Q4 25 | $-1.2B | $46.6M | ||
| Q3 25 | $36.2M | $33.9M | ||
| Q2 25 | $30.1M | $2.6M | ||
| Q1 25 | $8.4M | $24.6M | ||
| Q4 24 | $32.6M | $45.6M | ||
| Q3 24 | $68.1M | $51.7M | ||
| Q2 24 | $78.5M | $43.8M |
| Q1 26 | — | — | ||
| Q4 25 | — | 80.4% | ||
| Q3 25 | — | 80.1% | ||
| Q2 25 | — | 79.9% | ||
| Q1 25 | — | 79.3% | ||
| Q4 24 | — | 80.5% | ||
| Q3 24 | — | 80.0% | ||
| Q2 24 | — | 80.9% |
| Q1 26 | — | — | ||
| Q4 25 | -142.4% | 1.0% | ||
| Q3 25 | 4.7% | -0.7% | ||
| Q2 25 | 5.8% | -4.3% | ||
| Q1 25 | 1.7% | -1.6% | ||
| Q4 24 | 4.9% | 1.3% | ||
| Q3 24 | 12.1% | 2.9% | ||
| Q2 24 | 13.4% | 2.0% |
| Q1 26 | 0.5% | — | ||
| Q4 25 | -143.3% | 4.9% | ||
| Q3 25 | 4.3% | 3.8% | ||
| Q2 25 | 3.5% | 0.3% | ||
| Q1 25 | 1.1% | 3.2% | ||
| Q4 24 | 4.2% | 6.2% | ||
| Q3 24 | 8.4% | 7.5% | ||
| Q2 24 | 9.9% | 6.8% |
| Q1 26 | $0.05 | — | ||
| Q4 25 | $-12.98 | $0.13 | ||
| Q3 25 | $0.40 | $0.10 | ||
| Q2 25 | $0.33 | $0.01 | ||
| Q1 25 | $0.09 | $0.07 | ||
| Q4 24 | $0.36 | $0.14 | ||
| Q3 24 | $0.74 | $0.14 | ||
| Q2 24 | $0.85 | $0.12 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $158.5M | $401.3M |
| Total DebtLower is stronger | $2.5B | — |
| Stockholders' EquityBook value | $2.0B | $3.7B |
| Total Assets | $5.5B | $6.6B |
| Debt / EquityLower = less leverage | 1.29× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $158.5M | — | ||
| Q4 25 | $133.2M | $401.3M | ||
| Q3 25 | $118.7M | $540.6M | ||
| Q2 25 | $131.4M | $489.0M | ||
| Q1 25 | $91.2M | $1.1B | ||
| Q4 24 | $76.3M | $1.2B | ||
| Q3 24 | $82.1M | $337.4M | ||
| Q2 24 | $77.2M | $411.0M |
| Q1 26 | $2.5B | — | ||
| Q4 25 | $2.5B | — | ||
| Q3 25 | $2.3B | — | ||
| Q2 25 | $2.3B | — | ||
| Q1 25 | $2.2B | — | ||
| Q4 24 | $2.0B | — | ||
| Q3 24 | $1.9B | — | ||
| Q2 24 | $1.8B | — |
| Q1 26 | $2.0B | — | ||
| Q4 25 | $1.9B | $3.7B | ||
| Q3 25 | $3.1B | $3.4B | ||
| Q2 25 | $3.1B | $3.2B | ||
| Q1 25 | $3.0B | $2.9B | ||
| Q4 24 | $3.1B | $2.7B | ||
| Q3 24 | $3.0B | $2.6B | ||
| Q2 24 | $3.0B | $2.4B |
| Q1 26 | $5.5B | — | ||
| Q4 25 | $5.5B | $6.6B | ||
| Q3 25 | $6.4B | $6.1B | ||
| Q2 25 | $6.3B | $5.8B | ||
| Q1 25 | $6.1B | $6.0B | ||
| Q4 24 | $6.0B | $5.8B | ||
| Q3 24 | $5.9B | $4.6B | ||
| Q2 24 | $5.7B | $4.4B |
| Q1 26 | 1.29× | — | ||
| Q4 25 | 1.28× | — | ||
| Q3 25 | 0.74× | — | ||
| Q2 25 | 0.74× | — | ||
| Q1 25 | 0.72× | — | ||
| Q4 24 | 0.64× | — | ||
| Q3 24 | 0.62× | — | ||
| Q2 24 | 0.62× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $61.5M | $327.1M |
| Free Cash FlowOCF − Capex | — | $318.2M |
| FCF MarginFCF / Revenue | — | 33.4% |
| Capex IntensityCapex / Revenue | — | 0.9% |
| Cash ConversionOCF / Net Profit | 13.78× | 7.02× |
| TTM Free Cash FlowTrailing 4 quarters | — | $1.0B |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $61.5M | — | ||
| Q4 25 | $-86.3M | $327.1M | ||
| Q3 25 | $73.2M | $251.5M | ||
| Q2 25 | $133.5M | $200.1M | ||
| Q1 25 | $11.5M | $271.5M | ||
| Q4 24 | $116.7M | $265.2M | ||
| Q3 24 | $163.1M | $228.7M | ||
| Q2 24 | $171.1M | $164.4M |
| Q1 26 | — | — | ||
| Q4 25 | $-179.5M | $318.2M | ||
| Q3 25 | $-63.0M | $234.7M | ||
| Q2 25 | $-34.2M | $184.9M | ||
| Q1 25 | $-163.2M | $262.8M | ||
| Q4 24 | $-86.8M | $257.5M | ||
| Q3 24 | $-27.1M | $220.3M | ||
| Q2 24 | $16.9M | $160.0M |
| Q1 26 | — | — | ||
| Q4 25 | -21.8% | 33.4% | ||
| Q3 25 | -7.4% | 26.5% | ||
| Q2 25 | -3.9% | 22.4% | ||
| Q1 25 | -21.2% | 34.5% | ||
| Q4 24 | -11.2% | 34.9% | ||
| Q3 24 | -3.3% | 31.9% | ||
| Q2 24 | 2.1% | 24.8% |
| Q1 26 | — | — | ||
| Q4 25 | 11.3% | 0.9% | ||
| Q3 25 | 16.0% | 1.9% | ||
| Q2 25 | 19.3% | 1.8% | ||
| Q1 25 | 22.7% | 1.1% | ||
| Q4 24 | 26.3% | 1.1% | ||
| Q3 24 | 23.3% | 1.2% | ||
| Q2 24 | 19.4% | 0.7% |
| Q1 26 | 13.78× | — | ||
| Q4 25 | — | 7.02× | ||
| Q3 25 | 2.02× | 7.42× | ||
| Q2 25 | 4.43× | 75.58× | ||
| Q1 25 | 1.37× | 11.02× | ||
| Q4 24 | 3.58× | 5.82× | ||
| Q3 24 | 2.39× | 4.42× | ||
| Q2 24 | 2.18× | 3.75× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ACHC
| Acute Inpatient Psychiatric Facilities | $471.0M | 57% |
| Other | $140.0M | 17% |
| Specialty Treatment Facilities | $128.0M | 15% |
| Residential Treatment Facilities | $90.0M | 11% |
DDOG
| North America | $678.7M | 71% |
| International | $274.5M | 29% |
